查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1438170

2030 年医疗植入市场预测：按产品、材料、最终用户和地区分類的全球分析

Medical Implant Market Forecasts to 2030 - Global Analysis By Product, Material, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球医疗植入市场规模将达到985亿美元，预计2030年将达到1,825亿美元，预测期内复合年增长率为9.2%。

医疗植入市场旨在透过手术植入体内，用于替换或支撑受损的生物结构、增强身体功能和监测健康状况等目的。植入式医疗设备有多种用途，包括恢復器官功能、治疗慢性疾病和提高运动表现。此外，人工电子耳可以帮助恢復听力，胰岛素帮浦可以帮助控製糖尿病。这些设备不仅有助于延长和改善生命，还可以帮助患者恢復功能。

根据美国癌症协会2023年发布的报告，2022年美国女性将诊断出297,790例新的侵袭性乳癌病例，而马苏的新病例为287,850例。根据美学协会统计，2021年共有147,684例乳房植入移除/置换手术，占手术收入的6%。

医疗支出不断增长

随着各国投入大量财政资源来加强医疗基础设施和服务，先进医疗技术（包括植入设备）的取得和采用也不断增加。随着对提供优质医疗保健的重视，不断增加的医疗保健成本意味着对医疗干预措施进步的承诺，特别是植入式设备，它为各种医疗状况提供先进、有效且常常危及生命的治疗方法，已成为重要组成部分。

高成本

复杂的研究、开发和製造流程，加上严格的监管核准的需要，导致製造成本高昂。因此，这些成本通常会转嫁给医疗保健提供者，进而转嫁给患者，使植入式解决方案在经济上造成负担。这些高昂的经济障碍可能会限制医疗植入的取得，并阻碍患者选择这些先进的治疗方法，特别是在医疗保健预算有限的地区。然而，成本因素加剧了现有的医疗保健差距，因为负担不起的患者很难获得尖端的植入式医疗设备。

患者对植入式解决方案的偏好

由于生活品质提高和长期治疗结果等明显的好处，患者越来越多地选择植入式设备而不是传统治疗方法。无论是用于整形外科疾病的关节假体还是用于慢性疼痛管理的神经刺激设备，患者都欣赏许多植入提供的增强功能和活动性的潜力。此外，对美容植入（例如乳房植入和牙科修补）的接受度不断提高，反映出社会更广泛地转向接受有助于整体福祉和自尊的医疗干预措施。

併发症和失败风险

患者和医疗保健提供者通常对与植入手术相关的潜在不良后果（从仪器故障到术后併发症）持谨慎态度。对医疗植入安全性和有效性的担忧导致患者和医疗保健专业人员犹豫不决，阻碍了这些技术的普及。然而，设备故障或併发症的案例不仅会伤害患者，还会引发法律和监管审查，进一步减缓市场发展。

COVID-19 的影响：

全球健康危机造成的直接损害导致择期手术的延迟和取消，影响了对各种医疗植入的需求。医院和医疗保健机构已将重点和资源转移到管理 COVID-19 病例激增上，从而转移了对非紧急程序的注意力。然而，供应链中断、流动限制和製造放缓也阻碍了医疗植入的生产和分销。

预计整形外科植入领域在预测期内将是最大的

由于骨关节炎、骨折和肌肉骨骼疾病等整形外科疾病的发病率上升以及全球人口老化，预计整形外科植入领域将在预测期内占据最大份额。随着人们寻求增加活动能力和提高生活质量，对整形外科植入（包括人工关节和脊椎移植）的需求正在迅速增加。此外，微创手术的成长趋势进一步推动了对整形外科植入的需求。这是因为这些手术通常恢復时间较短且术后併发症较少。

预计门诊手术中心产业在预测期内将呈现最高的复合年增长率。

门诊手术中心透过提供比传统医院更具成本效益、高效且以患者为中心的替代方案，正在改变医疗保健服务。与传统医院相比，病人越来越喜欢ASC，因为它方便、手术时间更短、感染风险更低。强调个人化和专业护理的医学进步进一步推动了 ASC 对医疗植入的需求。

比最大的地区

先进的医疗基础设施和快速老化的人口相结合，使北美在整个估计期间占据了最大的市场份额。该国完善的医疗保健体系，加上有利的报销环境，支持尖端植入技术的采用。此外，医疗提供者、製造商和监管机构之间的策略合作伙伴关係促进了高效的核准流程，并确保新的和改进的医疗植入及时进入市场。

复合年增长率最高的地区：

预计亚太地区在整个预测期内将实现获利成长。经济的快速发展和对技术进步的日益关注正在促进该地区的崛起。特别是中阶人口的增加和医疗意识的提高，导致各个治疗领域对医疗植入的需求增加。中国、印度和日本等国家的监管机构正在积极努力简化核准流程，以确保创新且安全的医疗植入有效地推向市场。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球医疗植入市场：依产品

  • 整形外科植入
    • 髋关节整形外科器
    • 关节重组
    • 膝关节整形外科器
    • 脊椎整形外科器械
    • 其他的
  • 心血管植入
    • 结构性心臟植入
    • 起搏器
    • 其他的
  • 眼科植入
    • 青光眼植入
    • 人工水晶体
    • 其他的
  • 隆乳手术
  • 人工植牙
  • 其他的

第六章全球医疗植入市场：依材料分类

  • 陶瓷生物材料
  • 天然生物材料
  • 高分子生物材料
  • 金属生物材料
  • 其他的

第七章全球医疗植入市场：依最终用户分类

  • 医院
  • 门诊手术中心
  • 其他的

第八章全球医疗植入市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • 3M Company
  • Abbott Laboratories
  • Biotronik, Inc
  • Boston Scientific Corporation
  • Institut Straumann AG
  • Johnson & Johnson Medical GmbH
  • Livanova Plc
  • Medtronic plc
  • Novartis International AG
  • Smith & Nephew plc
  • Stryker Corporation
Product Code: SMRC25139

According to Stratistics MRC, the Global Medical Implant Market is accounted for $98.5 billion in 2023 and is expected to reach $182.5 billion by 2030 growing at a CAGR of 9.2% during the forecast period. The medical implant market is designed to be surgically placed within the body to replace or support damaged biological structures, enhance bodily functions, or monitor health conditions. Implantable medical devices serve diverse purposes, such as restoring organ function, managing chronic diseases, and improving mobility. Additionally, cochlear implants help restore hearing, while insulin pumps aid in diabetes management. These devices not only contribute to extending and improving lives but also enable patients to regain functionality.

According to the report published by the American Cancer Society in 2023, 297,790 new cases of invasive breast cancer will be diagnosed in women in the United States compared to 287,850 new breast cancer cases in 2022. According to the Aesthetic Society Statistics, in 2021, there were 147,684 breast implant removal/replacement procedures constituting 6% of surgical revenue.

Market Dynamics:

Driver:

Growing healthcare expenditures

As nations allocate substantial financial resources to enhance healthcare infrastructure and services, there is a parallel increase in the accessibility and adoption of advanced medical technologies, including implantable devices. With a growing emphasis on providing high-quality healthcare, the rise in healthcare expenditures signifies a commitment to advancing medical interventions, and implantable devices, in particular, become integral components in delivering sophisticated, effective, and often life-enhancing solutions for a range of medical conditions.

Restraint:

High cost

The intricate research, development, and manufacturing processes, coupled with the need for stringent regulatory approvals, contribute to elevated production costs. Consequently, these expenses are often transferred to healthcare providers and, ultimately, patients, making implantable solutions financially burdensome. This high economic barrier limits the accessibility of medical implants, particularly in regions with constrained healthcare budgets, and may deter patients from pursuing these advanced treatment options. However, the cost factor exacerbates existing healthcare disparities, as individuals with limited financial means may face challenges in accessing cutting-edge implantable devices.

Opportunity:

Patient preference for implantable solutions

Patients are opting for implantable devices over traditional treatment modalities due to the perceived advantages they offer in terms of improved quality of life and long-term therapeutic benefits. Patients appreciate the potential for enhanced functionality and mobility that many implants provide, whether it is artificial joints for orthopedic conditions or neurostimulators for chronic pain management. Additionally, the growing acceptance of cosmetic implants, such as breast implants or dental prosthetics, reflects a broader societal shift towards embracing medical interventions that contribute to overall well-being and self-esteem.

Threat:

Risk of complications and failures

Patients and healthcare providers alike are often cautious about the potential adverse outcomes associated with implant procedures, ranging from device malfunctions to post-operative complications. Concerns about the safety and efficacy of medical implants can lead to hesitancy among both patients and healthcare professionals, thereby impeding the widespread adoption of these technologies. However, instances of device failures or complications can not only result in harm to patients but may also trigger legal and regulatory scrutiny, further dampening market.

Covid-19 Impact:

The immediate disruption caused by the global health crisis led to elective surgeries being postponed or canceled, affecting the demand for various medical implants. Hospitals and healthcare facilities shifted their focus and resources towards managing the surge in Covid-19 cases, diverting attention from non-urgent procedures. However, supply chain disruptions, restrictions on movement, and manufacturing slowdowns also hampered the production and distribution of medical implants.

The orthopedic implants segment is expected to be the largest during the forecast period

Due to the rising incidence of orthopedic conditions such as osteoarthritis, fractures, and musculoskeletal disorders, coupled with an aging global population, Orthopedic Implants segment is expected to hold the largest share over the projection period. As individuals seek enhanced mobility and improved quality of life, the demand for orthopedic implants, including joint replacements and spinal implants, has surged. Furthermore, the increasing trend towards minimally invasive surgical procedures has further fueled the demand for orthopedic implants, as these procedures often involve shorter recovery times and reduced post-operative complications.

The ambulatory surgical centers segment is expected to have the highest CAGR during the forecast period

Due to a shift in healthcare delivery by providing a more cost-effective, efficient, and patient-centric alternative to traditional hospital settings, Ambulatory Surgical Centers segment is poised to witness lucrative growth during the extrapolated period. Patients increasingly prefer ASCs for their convenience, quicker turnaround times, and lower infection risks compared to traditional hospitals. The demand for medical implants in ASCs is further fueled by the evolving landscape of healthcare, emphasizing personalized and specialized care.

Region with largest share:

Owing to a combination of advanced healthcare infrastructure and a rapidly aging population, North America commanded the largest share of the market throughout the extrapolated period. The country's well-established healthcare system, coupled with a favorable reimbursement landscape, encourages the adoption of cutting-edge implant technologies. Moreover, strategic collaborations between healthcare providers, manufacturers, and regulatory bodies facilitate efficient approval processes, ensuring timely market entry for new and improved medical implants.

Region with highest CAGR:

Asia Pacific region is estimated to witness profitable growth throughout the forecast period. Rapid economic development and a growing focus on technological advancements contribute to the region's prominence. In particular, the rising middle-class population, coupled with improved healthcare awareness, has led to an escalating demand for medical implants across various therapeutic areas. Regulatory bodies in countries such as China, India, and Japan are actively working to streamline approval processes, ensuring that innovative and safe medical implants enter the market efficiently.

Key players in the market

Some of the key players in Medical Implant market include 3M Company, Abbott Laboratories, Biotronik, Inc, Boston Scientific Corporation, Institut Straumann AG, Johnson & Johnson Medical GmbH, Livanova Plc, Medtronic plc, Novartis International AG, Smith & Nephew plc and Stryker Corporation.

Key Developments:

In March 2023, Miach Orthopaedics, Inc. entered a distribution agreement with Veteran's Health Medical Supply (VHMS). The agreement provides customers in 236 Department of Defense (DOD) and Department of Veterans Affairs (VA) healthcare facilities access to the Bridge Enhanced ACL Restoration (BEAR) Implant via the ECAT federal contract.

In February 2023, CurvaFix, Inc. launched its smaller-diameter, 7.5mm CurvaFix IM Implant, designed to simplify surgery and provide strong, stable fixation in small-boned patients.

In April 2022, 3M presently declared that it has gained the technology assets of LeanTec. The acquisition displays 3M's dedication to its "connected bodyshop". The LeanTec technology augments 3M™ RepairStack™ Performance Solutions.

In February 2022, Abbott declared the world's earliest patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i™ pivotal clinical investigation. The implant of Abbott's investigational Aveir™ dual-chamber leadless pacemaker depicts a considerable technological milestone for leadless pacing technology.

Products Covered:

  • Orthopedic Implants
  • Cardiovascular Implants
  • Ophthalmic Implants
  • Breast Implants
  • Dental Implants
  • Other Products

Materials Covered:

  • Ceramic Biomaterial
  • Natural Biomaterial
  • Polymers Biomaterial
  • Metallic Biomaterial
  • Other Materials

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medical Implant Market, By Product

  • 5.1 Introduction
  • 5.2 Orthopedic Implants
    • 5.2.1 Hip Orthopaedic Device
    • 5.2.2 Joint Reconstruction
    • 5.2.3 Knee Orthopedic Devices
    • 5.2.4 Spine Orthopedic Devices
    • 5.2.5 Other Orthopedic Implants
  • 5.3 Cardiovascular Implants
    • 5.3.1 Structural Cardiac Implants
    • 5.3.2 Pacing Devices
    • 5.3.3 Other Cardiovascular Implants
  • 5.4 Ophthalmic Implants
    • 5.4.1 Glaucoma Implants
    • 5.4.2 Intraocular Lens
    • 5.4.3 Other Ophthalmic Implants
  • 5.5 Breast Implants
  • 5.6 Dental Implants
  • 5.7 Other Products

6 Global Medical Implant Market, By Material

  • 6.1 Introduction
  • 6.2 Ceramic Biomaterial
  • 6.3 Natural Biomaterial
  • 6.4 Polymers Biomaterial
  • 6.5 Metallic Biomaterial
  • 6.6 Other Materials

7 Global Medical Implant Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Other End Users

8 Global Medical Implant Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 3M Company
  • 10.2 Abbott Laboratories
  • 10.3 Biotronik, Inc
  • 10.4 Boston Scientific Corporation
  • 10.5 Institut Straumann AG
  • 10.6 Johnson & Johnson Medical GmbH
  • 10.7 Livanova Plc
  • 10.8 Medtronic plc
  • 10.9 Novartis International AG
  • 10.10 Smith & Nephew plc
  • 10.11 Stryker Corporation

List of Tables

  • Table 1 Global Medical Implant Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Medical Implant Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Medical Implant Market Outlook, By Orthopedic Implants (2021-2030) ($MN)
  • Table 4 Global Medical Implant Market Outlook, By Hip Orthopaedic Device (2021-2030) ($MN)
  • Table 5 Global Medical Implant Market Outlook, By Joint Reconstruction (2021-2030) ($MN)
  • Table 6 Global Medical Implant Market Outlook, By Knee Orthopedic Devices (2021-2030) ($MN)
  • Table 7 Global Medical Implant Market Outlook, By Spine Orthopedic Devices (2021-2030) ($MN)
  • Table 8 Global Medical Implant Market Outlook, By Other Orthopedic Implants (2021-2030) ($MN)
  • Table 9 Global Medical Implant Market Outlook, By Cardiovascular Implants (2021-2030) ($MN)
  • Table 10 Global Medical Implant Market Outlook, By Structural Cardiac Implants (2021-2030) ($MN)
  • Table 11 Global Medical Implant Market Outlook, By Pacing Devices (2021-2030) ($MN)
  • Table 12 Global Medical Implant Market Outlook, By Other Cardiovascular Implants (2021-2030) ($MN)
  • Table 13 Global Medical Implant Market Outlook, By Ophthalmic Implants (2021-2030) ($MN)
  • Table 14 Global Medical Implant Market Outlook, By Glaucoma Implants (2021-2030) ($MN)
  • Table 15 Global Medical Implant Market Outlook, By Intraocular Lens (2021-2030) ($MN)
  • Table 16 Global Medical Implant Market Outlook, By Other Ophthalmic Implants (2021-2030) ($MN)
  • Table 17 Global Medical Implant Market Outlook, By Breast Implants (2021-2030) ($MN)
  • Table 18 Global Medical Implant Market Outlook, By Dental Implants (2021-2030) ($MN)
  • Table 19 Global Medical Implant Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 20 Global Medical Implant Market Outlook, By Material (2021-2030) ($MN)
  • Table 21 Global Medical Implant Market Outlook, By Ceramic Biomaterial (2021-2030) ($MN)
  • Table 22 Global Medical Implant Market Outlook, By Natural Biomaterial (2021-2030) ($MN)
  • Table 23 Global Medical Implant Market Outlook, By Polymers Biomaterial (2021-2030) ($MN)
  • Table 24 Global Medical Implant Market Outlook, By Metallic Biomaterial (2021-2030) ($MN)
  • Table 25 Global Medical Implant Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 26 Global Medical Implant Market Outlook, By End User (2021-2030) ($MN)
  • Table 27 Global Medical Implant Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 28 Global Medical Implant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 29 Global Medical Implant Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.